Find disease awareness content and relevant supporting materials

Allergic rhinitis is a common disorder that regularly occurs in children and adolescents. The disease is associated with other allergic diseases, such as asthma, and it carries a heavy burden, with effects on sleep, school performance...

Background: Patients with allergic rhinitis often trivialise their condition, self-manage inappropriately, and would benefit from health care intervention.

The updated BSACI guideline for diagnosing and managing allergic and non-allergic rhinitis highlights the importance of accurate diagnosis and effective treatment strategies. It emphasizes the role of topical nasal corticosteroids and combination therapies, and discusses the impact of rhinitis on asthma development.

ALK has obtained European approval for its HDM-SLIT (house dust mite sublingual allergy immunotherapy tablet) against allergic rhinitis and allergic...

The next-generation ARIA guidelines for allergic rhinitis emphasize the use of GRADE and real-world evidence to improve treatment strategies. They highlight the MACVIA algorithm for personalized treatment adjustments.

Merck announced that the FDA has approved Grastek (Timothy Grass Pollen Allergen Extract) Tablet for Sublingual Use [2800 Bioequivalent Allergy...

The KAAACI guidelines for allergic rhinitis focus on pharmacotherapy, addressing key clinical questions for effective management. Recommendations include combination therapies and prophylactic treatments, though all are conditional due to low evidence certainty.

We investigated predictive biomarkers of disease evolution in a large cohort of children with SAR.

The Japanese guidelines for allergic rhinitis 2020 provide a comprehensive approach to diagnosing and managing allergic rhinitis, including pollinosis. They emphasize evidence-based strategies and address special populations such as children and pregnant women.

The KAAACI guidelines for allergic rhinitis focus on non-pharmacological management, including allergen-specific immunotherapy, nasal saline irrigation, and environmental strategies. These guidelines aim to improve quality of life by addressing recurrent symptoms with evidence-based recommendations.